TC Biopharm (Holdings) Plc
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 61.47 | -100% | -3.63 | -100% |
| P/S |
|
0 | 33.58 | -100% |
|
|
| P/BV |
|
0.2639 | 4.79 | -94.49% |
|
|
| P/FCF |
|
0 | 42.53 | -100% |
|
|
| Ev/Ebitda |
|
-0.0027 | -17.26 | -99.98% |
|
|
| Ev/S |
|
0 | 22.49 | -100% |
|
|
| Ev/FCF |
|
-0.0044 | 67.63 | -100.01% |
|
|
| E/P |
|
0 | 0.0182 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | -14.2 | -100% | -218.42 | -100% |
| ROE |
|
-280.43 | 9.78 | -2966.61% |
|
|
| ROA |
|
-84.31 | 0.33 | -25644.58% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
0 | -26.41 | -100% |
|
|
| ROCE |
|
-676.01 | 14.76 | -4680.67% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.1038 | -3.68 | -97.18% | -0.4217 | -75.38% |
| Nеt Debt/Ebitda |
|
0.0381 | -4.07 | -100.94% |
|
|
| Debt/Ratio |
|
0.2017 | 0.199 | 1.33% |
|
|
| Debt/Equity |
|
0 | 1.67 | -100% |
|
|
| Debt/Net Income |
|
-0.2392 | 10.34 | -102.31% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5399 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.235 | -100% |
|
|
| Average dividend growth |
|
0 | 1.41 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.486 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.64 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5399 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
2/10
|
12.19 | 76.2 | -84% | ||
| Growth impulse Ebitda in 5 years |
|
138.17 | 44.75 | 208.76% | ||
| Growth impulse Net Income in 5 years |
|
-2.65 | -15.36 | -82.75% | ||
| Growth impulse FCF in 5 years |
|
19.37 | -31.68 | -161.14% | ||
| Growth impulse EPS in 5 years |
|
1294.7 | -61.82 | -2194.31% |
IP Score
3.75/10
